Human medicines European public assessment report (EPAR): Cialis, tadalafil, Date of authorisation: 12/11/2002, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Forsteo, teriparatide, Date of authorisation: 10/06/2003, Revision: 25, Status: Authorised
Handling competing interests
EMEA-001745-PIP01-14
EMEA-002572-PIP02-19-M05
Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil, Date of authorisation: 01/10/2008, Revision: 19, Status: Authorised
Medicinal products for human use: monthly figures - December 2025
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 12, Status: Authorised
Agenda - PDCO agenda of the 27-30 January 2026 meeting
Scientific Advisory Group on Vaccines and Therapies for Infectious Diseases (SAG-V&ID)